Clinical Skin Findings in 1,321 Korean Military Personnel
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional activity or service setting. It is not a patient, diagnosis, before-and-after image, institutional endorsement or Dr. Arsy #003 treatment result.
Reader question: What did this specific study measure, in whom, at what timepoint—and which conclusions would go beyond its evidence?
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 1,321 Korean military personnel who received a dermatologic examination. |
| Design | Cross-sectional clinical examination describing the frequency and distribution of skin disease in a military population. |
| Comparator | Condition categories were compared descriptively within the examined group; there was no civilian control group. |
| Timepoint | One dermatologic assessment. |
| Key result | Skin disease was identified in 798 of 1,321 personnel (60.4%). Acne was recorded in 35.6%, tinea pedis in 15.2% and atopic dermatitis in 5.1%. |
| Funding/conflict context | The accessible PubMed abstract does not state funding or conflict disclosures. No moisturizer was evaluated. |
What was actually measured?
Skin disease was identified in 798 of 1,321 personnel (60.4%). Acne was recorded in 35.6%, tinea pedis in 15.2% and atopic dermatitis in 5.1%.
A clinician-performed examination gives more specificity than symptom self-report, but the broad outcome combines conditions with very different causes and management.
The denominator defines the scope. A clinic series, outbreak investigation, surveillance database, questionnaire and prospective cohort answer different questions. Their percentages, rates and associations cannot be silently transferred to a different population, activity or setting.
What the result does not prove
Cross-sectional timing, one national military setting, no civilian comparator and no exposure-specific analysis limit causal and international generalization.
Observational timing and association do not automatically prove individual causation. Training load, footwear, shared surfaces, hygiene, climate, protective equipment, prior conditions, referral practices and access to care may all change an estimate.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors’ conclusions, this interpretation or any product.
Condition categories should stay separate
Dryness, friction injury, dermatitis, fungal disease and bacterial infection are not interchangeable. A moisturizer may support hydration and the moisture barrier, but it does not diagnose an infection, replace medical evaluation or substitute for activity-specific prevention and infection-control measures.
For suspected infection, clinicians may need examination, microscopy, culture or other testing. Persistent spreading redness, drainage, fever, severe pain, rapidly worsening symptoms or major loss of function warrants prompt professional evaluation.
Activity details worth documenting
- Which surface, footwear, glove, mat, pool, uniform, climate or training load came before the change?
- Where did the problem begin, and did it change during rest, travel, deployment or a different facility?
- Were skin, towels, clothing, equipment or showers shared, and how were surfaces cleaned?
- How often were skin areas wet, occluded, rubbed, heated, chilled or exposed to sun?
- Did the problem alter sleep, pace, attendance, training, competition or work safety?
Prevention comes before cosmetic care
Useful prevention is matched to the hazard: equipment and facility hygiene, prompt showering, clean personal textiles, well-fitted footwear, friction management, task-appropriate protective equipment, ultraviolet protection and timely clinical assessment. No single step prevents every diagnosis.
Do not share personal skin products during an outbreak and do not place workplace or environmental materials on skin to test a theory. Follow facility, occupational-health, sports-medicine and public-health instructions for contagious conditions.
Primary research and authoritative guidance
- Primary research record: PubMed PMID 23091325
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: eczema skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema or infection, relieves pain or itch, neutralizes environmental exposures, is appropriate for every person, or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Dermatitis Findings Across California Grape, Citrus and Tomato Workers
- Three-Year Skin-Problem Risk Across 6,745 Norwegian Workers
- Eight-Week Skin-Problem Reports in 87 University Athletes
- Foot Findings in 51 Professional Dancers Before and After Rest
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace, military, sports or infection-control determination.